The fractional concentration of nitric oxide in exhaled air from the lower respiratory tract (CaNO) in ILD patients is higher than that in healthy individuals, indicating that inducible nitric oxide synthase (iNOS) is activated during the stage of pulmonary fibrosis involvement. This evidence concerns the gene NOS2 and pulmonary fibrosis.